News from genomedx biosciences A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 05, 2015, 08:00 ET

GenomeDx Biosciences to Present at 2015 Wedbush PacGrow Healthcare Conference

GenomeDx Biosciences announced that it will present at the Wedbush PacGrow Healthcare Conference at 9:45 a.m. ET on Wednesday, August 12, in...

Aug 04, 2015, 08:00 ET

Decipher® Predicts Metastasis and Identifies Biomarkers Predictive of Aggressive Disease in African American Men

 GenomeDx Biosciences announced today that its commercially-available Decipher® testing platform identified, with statistical...

Jul 14, 2015, 08:00 ET

New Study Published on Cover of Urology Finds that Decipher® Prostate Cancer Classifier Reduces Conflicting Treatment Recommendations between Urologists and Radiation Oncologists

 GenomeDx Biosciences today announced that a study featured on the cover of Urology demonstrates that Decipher® Prostate Cancer Classifier...

Jun 30, 2015, 08:00 ET

GenomeDx Announces Exclusive Marketing and Distribution Agreement for the Decipher Prostate Cancer Classifier in Israel and the Palestinian Authority

 GenomeDx Biosciences today announced that the company signed an exclusive agreement with Medison Pharma Ltd., a leading marketer of innovative...

Jun 25, 2015, 08:00 ET

GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology

 GenomeDx Biosciences today announced that a study published in European Urology showed that its Decipher® Prostate Cancer Classifier...

Jun 01, 2015, 17:45 ET

GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting

GenomeDx Biosciences today announced that the robust Decipher® genomic analysis platform, successfully classified various subtypes of bladder...

May 30, 2015, 14:15 ET
May 28, 2015, 08:00 ET

Study published in European Urology demonstrates utility of Decipher GRID™ to evaluate ERG and other new markers with prognostic value in prostate cancer

 GenomeDx Biosciences today announced the publication of a multi-institutional validation study titled "Characterization of 1,577 primary...

May 18, 2015, 11:30 ET

GenomeDx to Present New Data on Genomic Testing for Bladder Cancer at American Urological Association Annual Meeting

 GenomeDx Biosciences today announced that the company has identified a genomic signature that is predictive of metastasis in patients with...

May 15, 2015, 11:30 ET

Multiple Studies at American Urological Association Annual Meeting Highlight Accuracy, Broad Applicability of GenomeDx's Decipher Test for Prostate Cancer

GenomeDx Biosciences announced that three abstracts presented today at the American Urological Association Annual Meeting in New Orleans featuring...

May 13, 2015, 17:49 ET

GenomeDx to present new data in Prostate and Bladder Cancer at the 2015 American Society of Clinical Oncology Annual Meeting

 GenomeDx Biosciences today announced that multiple studies featuring clinical data from the company's Decipher platform will be presented at...

May 12, 2015, 08:00 ET

GenomeDx Announces Launch of Decipher GRID™ and Partnership with Sidney Kimmel Cancer Center to Accelerate Innovation in Urologic Cancer Patient Care

 GenomeDx Biosciences today announced the launch of the Decipher® Genomics Resource Information Database (Decipher GRID™), a...

May 08, 2015, 08:00 ET

GenomeDx's Decipher Test and Tissue-based Genomics Platform to be Featured in Nine Presentations at the American Urological Association Annual Meeting

GenomeDx Biosciences today announced that eight abstracts featuring the Decipher® Prostate Cancer Classifier, a genomic test for prostate...

Feb 24, 2015, 09:00 ET

GenomeDx's Decipher Shows Broad Applicability in Advancing Prostate Cancer Care in Data Presented at 2015 ASCO Genitourinary Symposium

 GenomeDx Biosciences today announced that data presented at the 2015 ASCO Genitourinary Symposium shows further development of its prostate...

Feb 24, 2015, 08:00 ET

Data Presented at 2015 ASCO Genitourinary Symposium Compares, Validates and Demonstrates Utility for GenomeDx's Decipher Test

 GenomeDx Biosciences today announced that data to be presented at the 2015 ASCO Genitourinary Symposium demonstrates that its Decipher®...

Feb 09, 2015, 16:05 ET

Study Published in Journal of Clinical Oncology Finds that the Decipher® Prostate Cancer Test Predicts which Patients Benefit from Radiation Therapy Following Prostate Surgery

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic...

Jan 14, 2015, 23:49 ET

GenomeDx Secures Medicare Coverage for Decipher® Prostate Cancer Test

 GenomeDx Biosciences today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has issued a positive...

Dec 22, 2014, 08:00 ET

Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery

GenomeDx Biosciences today announced that a new study showed that the Decipher Prostate Cancer Classifier, a genomic test for prostate cancer, was...

Nov 11, 2014, 08:00 ET

GenomeDx and Mayo Clinic Enter Agreement to Conduct Validation Study of Decipher® Prostate Cancer Test in Patients Receiving Biopsy Prior to Treatment

 GenomeDx Biosciences today announced that the company has expanded its research agreement with Mayo Clinic to initiate a validation study to...

Oct 16, 2014, 22:52 ET

Centers for Medicare and Medicaid Services Publishes Draft Coverage Decision to Reimburse the Decipher® Test for Intermediate & High Risk Prostate Cancer

GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been...